Person

Terrence C. Kearney

Formerly Director, Vertex Pharmaceuticals

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$14.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 10, 2023VRTXSale10,000$350.00$3.5M
Nov 1, 2019VRTXSale3,159$200.00$632K
Nov 1, 2019VRTXSale20,000$200.00$4.0M
Nov 1, 2019VRTXSale375$200.00$75K
Nov 1, 2019VRTXSale20,000$200.00$4.0M
Nov 1, 2019VRTXSale7,073$200.00$1.4M
Oct 31, 2019VRTXSale1,841$200.00$368K

SEC reporting-owner ID (CIK) 1289098 · all filings on EDGAR